Skip to main content
MYUNGMOON PHARM CO.,LTD logo

MYUNGMOON PHARM CO.,LTD — Investor Relations & Filings

Ticker · 017180 ISIN · KR7017180001 KO Manufacturing
Open in API
Filings indexed 250 across all filing types
Latest filing 2023-05-25 Transaction in Own Shar…
Country KR South Korea
Listing KO 017180

About MYUNGMOON PHARM CO.,LTD

http://mmpharm.co.kr/en/main/

Myungmoon Pharm Co., Ltd. is a research-based pharmaceutical company engaged in the development, manufacturing, and commercialization of healthcare products. The company produces over 250 specialized and general medicines, holding more than 400 manufacturing licenses. Its portfolio includes both ethical (ETC) and over-the-counter (OTC) drugs, with key product areas in anesthetics, digestive agents, and antitussives. The company's operations encompass the wholesale, import, and export of its pharmaceutical products for domestic and international markets.

Recent filings

Filing Released Lang Actions
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Supervisory Service (금융위원회) regarding a decision to enter into a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). This is a corporate action related to share buybacks, which falls under the category of 'Transaction in Own Shares'.
2023-05-25 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Myungmoon Pharm Co., Ltd. for the period ending March 31, 2023. It contains detailed financial data, business operations, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details the shareholding status, changes in ownership, and collateral agreements of a major shareholder (Woo Seok-min) in Myungmoon Pharm. This type of filing is a mandatory disclosure to the Financial Supervisory Service (FSS) and the Korea Exchange (KRX) when significant shareholding thresholds are met or changed. It does not fit into the other specific categories like 10-K, Earnings Release, or M&A, making 'Regulatory Filings' (RNS) the most appropriate classification.
2023-04-12 Korean
[기재정정]사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Myungmoon Pharm Co., Ltd. for the 37th fiscal year (2022). It contains detailed financial information, management discussion, corporate governance, and operational data. Although it mentions a 'correction' (정정신고), it is a comprehensive annual filing submitted to the financial authorities, which corresponds to the 10-K category in the provided schema. FY 2022
2023-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director appointments, and remuneration limits. Since it reports the official outcomes of shareholder voting at an AGM, it falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2023-03-29 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Myungmoon Pharm Co., Ltd. for the fiscal year 2022 (Jan 1, 2022 - Dec 31, 2022). It contains detailed financial data, management discussion, business operations, and governance information, which corresponds to the standard format of an Annual Report (10-K) in the Korean regulatory context. FY 2022
2023-03-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.